Effect of Allopurinol for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome

Clinical trial NCT03162653 · UNKNOWN

Trial details

NCT number: NCT03162653
Sponsor: University Hospital Tuebingen
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Encephalopathy, Hypoxic-Ischemic Infant, Newborn, Diseases

Start date: 2018-03-25
Primary completion: 2026-01-31
Enrollment: 760

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.